Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2012 June;147(3) > Giornale Italiano di Dermatologia e Venereologia 2012 June;147(3):259-67

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

  AUTOIMMUNE BULLOUS DISEASES


Giornale Italiano di Dermatologia e Venereologia 2012 June;147(3):259-67

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: English

Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases

Daniel B. S. 1, 2, Murrell D. F. 1, 2

1 Department of Dermatology, St George Hospital, Sydney, NSW, Australia; 2 University of New South Wales, Sydney, NSW, Australia


PDF  


Autoimmune bullous diseases describes a heterogenous group of diseases with skin and mucosal involvement with varying degrees of mortality. Intravenous immunoglobulin (IVIg) is a specialised treatment used in the management of these AIBD with variable success. This paper outlines the use of IVIg in these diseases.

top of page

Publication History

Cite this article as

Corresponding author e-mail

d.murrell@unsw.edu.au